Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 875 across all filing types
Latest filing 2018-05-03 Capital/Financing Update
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical AB (publ) genomför finansiering om 7 MSEK genom emission av konvertibler och teckningsoptioner
Capital/Financing Update Classification · 99% confidence The document text is a press release announcing that Episurf Medical AB is conducting a financing round of 7 MSEK through the issuance of convertibles and warrants to a specific fund (ESGO). It details the terms of the issuance, the use of proceeds, and the anti-dilution measures (warrants to existing shareholders). This clearly falls under the category of corporate actions related to fundraising and capital structure changes. The definition for 'Capital/Financing Update' (CAP) matches this content perfectly. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it is highly specific to a financing event.
2018-05-03 Swedish
Episurf Medical AB (publ) acquires financing of SEK 7 million by issuing convertible notes and warrants
Capital/Financing Update Classification · 99% confidence The document explicitly details the acquisition of financing through the issuance of convertible notes and warrants, including specific amounts (SEK 7 million), the mechanism to counteract dilution by issuing free warrants to existing shareholders, and the terms of conversion/exercise. This activity directly relates to changes in the company's capital structure and fundraising efforts. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as the subject matter is highly specific to a financing transaction.
2018-05-03 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is a 'Kvartalsrapport' (Quarterly Report) for the period 1 January to 31 March 2018. It contains comprehensive financial statements, management commentary, operational highlights, and shareholder information. It is not an announcement of a report, but the report itself, and it contains substantive financial data, thus fitting the definition of an Interim/Quarterly Report (IR). Q1 2018
2018-04-27 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report, 1 January–31 March 2018' and contains comprehensive financial statements, including net sales, operating profit/loss, financial position, and human resources data for both the Group and the Parent Company. It also includes a CEO message, business updates, and shareholder information. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2018
2018-04-27 English
SUMMARY FROM ANNUAL GENERAL MEETING OF EPISURF MEDICAL AB (PUBL)
AGM Information Classification · 99% confidence The document explicitly states in the title and opening paragraph that it is a 'SUMMARY FROM ANNUAL GENERAL MEETING OF EPISURF MEDICAL AB'. It details resolutions passed regarding the approval of financial statements, election of the Board of Directors, auditor re-election, approval of remuneration guidelines, and the adoption of an employee stock option and warrant program. These are all typical outcomes and summaries presented following an Annual General Meeting (AGM). Therefore, the classification should be AGM-R.
2018-04-09 English
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I EPISURF MEDICAL AB (PUBL)
AGM Information Classification · 99% confidence The document is titled 'KOMMUNIKÉ FRÅN ÅRSSTÄMMA I EPISURF MEDICAL AB (PUBL)', which translates to 'COMMUNIQUÉ FROM THE ANNUAL GENERAL MEETING IN EPISURF MEDICAL AB (PUBL)'. The text details the decisions made at the meeting, including the approval of financial statements, election of the board, setting director fees, appointing the auditor, and approving a new employee stock option program. These are all core activities of an Annual General Meeting (AGM). Since the document is a summary/communiqué of the meeting outcomes rather than a presentation or voting result declaration, the most appropriate classification is AGM Information (AGM-R). The length (5077 chars) is substantial enough to be the primary report of the meeting's outcome, not just a brief announcement of publication (RPA/RNS).
2018-04-09 Swedish

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.